Citation Impact
Citing Papers
The 2017 hormone therapy position statement of The North American Menopause Society
2017
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
TOR Signaling in Growth and Metabolism
2006 Standout
A Report Template for Molecular Genetic Tests Designed to Improve Communication Between the Clinician and Laboratory
2012
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer
2006
Steroid Hormone Receptor Status of Mouse Mammary Stem Cells
2006
Triple-Negative Breast Cancer
2010 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Thiazolidinediones
2004 Standout
Osteoporosis
2019 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Clinical management of BRCA1 and BRCA2 mutation carriers
2006
Breast cancer
2016 Standout
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
1993 Standout
Accurate classification of BRCA1 variants with saturation genome editing
2018 Nature
Saturation variant interpretation using CRISPR prime editing
2022
Cell-cycle checkpoints and cancer
2004 StandoutNature
Ovarian cancer
2014 Standout
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
BRCA1 : mechanisms of inactivation and implications for management of patients
2002
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002
2013
Decision aids for people facing health treatment or screening decisions
2011
Breast and Ovarian Cancer
2003
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family
2003
Decision aids for people facing health treatment or screening decisions
2014
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Colorectal cancer
2013 Standout
Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study
2007
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
2004 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
2011
Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis
2005
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction.
2009
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
The Fanconi Anemia/BRCA pathway: new faces in the crowd
2005
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
2009
Cancer vaccines: between the idea and the reality
2003
Emerging Biological Principles of Metastasis
2017 Standout
Hereditary Colorectal Cancer
2003 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
TGFβ in Cancer
2008 Standout
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
2005
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
2010
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer
2006
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
2003
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Cancer of the Ovary
2004 Standout
Fifteen-year prognostic discriminants for invasive breast carcinoma
2001
Individualized Survival Curves Improve Satisfaction With Cancer Risk Management Decisions in Women With BRCA1/2 Mutations
2005
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
A Randomized Controlled Trial of a Decision Aid for Women at Increased Risk of Ovarian Cancer
2006
Decision aids for people facing health treatment or screening decisions
2017 Standout
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer
2009
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
2005
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs
2012 StandoutScience
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.
2002
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
2009
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease
2016
Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway
2008
Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization
2011
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
2003
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
2006
Shared Decision Making — The Pinnacle of Patient-Centered Care
2012 Standout
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
A Randomized, Controlled Trial to Increase Discussion of Breast Cancer in Primary Care
2014
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations
2000
Works of Ellen Matloff being referenced
Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study
2008
Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations
2002
The breast surgeon’s role in BRCA1 and BRCA2 testing
2000
Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers
2007
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
2002
Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway
2003
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study
2006
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making
2006
BRCA1/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1/BRCA2 Mutations
1999
Errors in delivery of cancer genetics services: implications for practice.
2010
What Would You Do? Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination
2000
Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history.
1998
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2004